会议专题

Efficacy and Safety of Low-dose Tirofiban in Aged Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

BACKGROUND: Studies have shown that percutaneous coronary intervention combined with tirofiban therapy could improve the blood supply of heart and reduce cardiac infarction.This study aimed to study the efficacy and safety of low-dose tirofiban in the treatment of elderly patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention.

L.Ren W.G.Wang Q.Wang J.Zhang X.Y.Tang J.S.Feng H.M.Yang Q.S.Wang

The First Hospital of Qinhuangdao,Qinhuangdao, China

国内会议

2015中国老年医学和老年健康产业大会

苏州

英文

335-335

2015-09-11(万方平台首次上网日期,不代表论文的发表时间)